PMCB logo

PharmaCyte Biotech (PMCB) Depreciation And Amortization

Annual D&A

N/A

30 April 2024

PMCB Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

N/A

31 July 2024

PMCB Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

N/A

31 July 2024

PMCB TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PMCB Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

PMCB Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

PharmaCyte Biotech Depreciation And Amortization History

DateAnnualQuarterlyTTM
Apr 2012
$24.70 K(-39.3%)
$800.00(-89.3%)
$24.70 K(-23.8%)
Jan 2012
-
$7500.00(-5.1%)
$32.40 K(-5.0%)
Oct 2011
-
$7900.00(-7.1%)
$34.10 K(-8.3%)
July 2011
-
$8500.00(0.0%)
$37.20 K(-8.6%)
Apr 2011
$40.70 K(-64.6%)
$8500.00(-7.6%)
$40.70 K(-25.7%)
Jan 2011
-
$9200.00(-16.4%)
$54.80 K(-24.7%)
Oct 2010
-
$11.00 K(-8.3%)
$72.80 K(-22.8%)
July 2010
-
$12.00 K(-46.9%)
$94.30 K(-18.0%)
Apr 2010
$114.90 K(+300.3%)
$22.60 K(-16.9%)
$115.00 K(+0.7%)
Jan 2010
-
$27.20 K(-16.3%)
$114.20 K(+27.9%)
Oct 2009
-
$32.50 K(-0.6%)
$89.30 K(+51.6%)
July 2009
-
$32.70 K(+50.0%)
$58.90 K(+105.2%)
Apr 2009
$28.70 K
$21.80 K(+847.8%)
$28.70 K(+215.4%)
Jan 2009
-
$2300.00(+9.5%)
$9100.00(+3.4%)
Oct 2008
-
$2100.00(-16.0%)
$8800.00(+12.8%)
DateAnnualQuarterlyTTM
July 2008
-
$2500.00(+13.6%)
$7800.00(+23.8%)
Apr 2008
$6400.00(+357.1%)
$2200.00(+10.0%)
$6300.00(+43.2%)
Jan 2008
-
$2000.00(+81.8%)
$4400.00(+57.1%)
Oct 2007
-
$1100.00(+10.0%)
$2800.00(+40.0%)
July 2007
-
$1000.00(+233.3%)
$2000.00(+53.8%)
Apr 2007
$1400.00(+180.0%)
$300.00(-25.0%)
$1300.00(0.0%)
Jan 2007
-
$400.00(+33.3%)
$1300.00(+18.2%)
Oct 2006
-
$300.00(0.0%)
$1100.00(-116.4%)
July 2006
-
$300.00(0.0%)
-$6700.00(-1440.0%)
Apr 2006
$500.00
$300.00(+50.0%)
$500.00(+150.0%)
Jan 2006
-
$200.00(-102.7%)
$200.00(>+9900.0%)
Oct 2005
-
-$7500.00(-200.0%)
$0.00(-100.0%)
July 2005
-
$7500.00(-568.8%)
$5900.00(>+9900.0%)
Oct 2004
-
-$1600.00(-200.0%)
$0.00(-100.0%)
July 2004
-
$1600.00
$1600.00

FAQ

  • What is the all time high annual D&A for PharmaCyte Biotech?
  • What is the all time high quarterly D&A for PharmaCyte Biotech?
  • What is the all time high TTM D&A for PharmaCyte Biotech?

What is the all time high annual D&A for PharmaCyte Biotech?

PharmaCyte Biotech all-time high annual depreciation & amortization is $114.90 K

What is the all time high quarterly D&A for PharmaCyte Biotech?

PharmaCyte Biotech all-time high quarterly depreciation & amortization is $32.70 K

What is the all time high TTM D&A for PharmaCyte Biotech?

PharmaCyte Biotech all-time high TTM depreciation & amortization is $115.00 K